Express Scripts Holding Company (NASDAQ:ESRX) registered a -2.35% decrease, still its new closing price is 4.86% up from the company’s 1 year high of 80.02.It posted -5.80% losses in previous 5 sessions and is now the subject of 12 analysts who together assign a hold rating on stock. 2 of Wall Street analysts have an underperform rating; the 0 sells versus 3 buy or better ratings. The 23 stock analysts following this company have an average price target at $81.11, with individual PT in the $59.00-$95.00 range. The shares moved at $67.59, implying that brokerage firms see shares losing about -3.25% in twelve months time.
Express Scripts Holding Company (ESRX) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a -1.74% fall year to date. A Sr. VP, Sup. Chain & Specialty at Express Scripts Holding Company (ESRX) offloaded shares in a transaction closed on Tuesday January 03, 2017. Neville Everett sold 1,123 shares in the company at $69.41 each and collected $77,001 in proceeds. Neville Everett now owns 12,712 shares in the company after this transaction. A Sr. VP & Chief Med. Officer in the company, Miller Steven B, disclosed a transaction on Wednesday November 09, 2016 that ended up generating $1,635,000 from the sale of 21,798 shares at $75.02 per share.
Express Scripts Holding Company (NASDAQ:ESRX) Upcoming Results on Tap
Express Scripts Holding Company will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $1.72 in that period. Sales during the quarter are predicted to arrive at $25.45 billion.
Earnings surprise history: Last quarter, the company posted approximately $25.41 billion in revenue and EPS of $1.74. The mean forecast was for $25.49 billion and $1.74 a share, respectively. One quarter earlier, revenue for the stock was at $25.22 billion, with earnings at $1.57/share.
Express Scripts Holding Company (ESRX) Brokerage Update
Express Scripts Holding Company (ESRX) is in Deutsche Bank’s research list so their analyst rating change is noteworthy. These shares were upgraded to Hold from Sell by Deutsche Bank, according to news reported on Friday November 04, 2016.Another important research note was issued by Morgan Stanley on Monday June 20, 2016.The firm downgraded ESRX to Underweight from Equal-Weight. Over the last six months and over the last three months, the shares of Express Scripts Holding Company (ESRX), have changed -12.32% and -3.98%, respectively.
